Methods and Compositions to use Shape Changing Polymers in Subterranean Formations
US-2016312098-A1 · Oct 27, 2016 · US
US10144858B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10144858-B2 |
| Application number | US-201415505578-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 25, 2014 |
| Priority date | Sep 25, 2014 |
| Publication date | Dec 4, 2018 |
| Grant date | Dec 4, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compositions including a curable resin and organophilically-modified clay for subterranean oil well applications and methods of using the same. A method of treating a subterranean formation including placing in a subterranean formation a curable composition that includes at least one of a curable organic resin and a thermosetting polymer. The curable composition also includes an organophilically-modified clay.
Opening claim text (preview).
What is claimed is: 1. A method of treating a subterranean formation, the method comprising: placing a curable composition in a subterranean formation, wherein the curable composition comprises: at least one of a curable organic resin and a thermosetting polymer; and an organophilically-modified clay comprising an organophilic-modification compound or an ion thereof, wherein the organophilic-modification compound is at least one of a substituted or unsubstituted (C 10 -C 50 ) fatty acid or a salt thereof, a tri- or tetra-(C 1 -C 50 ) hydrocarbylammonium salt, a tri- or tetra-(C 1 -C 50 ) hydrocarbylphosphonium salt, or combinations thereof, and wherein each tri- or tetra-(C 1 -C 50 ) hydrocarbylammonium salt, and tri- or tetra-(C 1 -C 50 ) hydrocarbylphosphonium salt is independently selected, is substituted or unsubstituted, and is interrupted by 0, 1, 2, or 3 atoms chosen from at least one of —O—, —S—, substituted or unsubstituted —NH—, or combinations thereof. 2. The method of claim 1 , wherein the organophilic-modification compound comprises a (C 10 -C 50 ) fatty acid salt. 3. The method of claim 1 , wherein the organophilic-modification compound comprises magnesium stearate and zinc stearate. 4. The method of claim 1 , wherein the organophilic-modification compound comprises at least one of a tri- or tetra-(C 1 -C 50 ) hydrocarbylammonium salt, a tri- or tetra-(C 1 -C 50 )alkyl- or alkenylphosphonium salt, or a combination thereof. 5. The method of claim 1 , wherein the organophilic-modification compound comprises at least one of a trimethyl stearyl ammonium salt, dodecyltrimethylammonium bromide, hexadecyltrimethylammonium bromide, tetradecyltrimethylammonium bromide, tetraphenylphosphonium bromide, or combinations thereof. 6. The method of claim 1 , wherein the curable composition comprises an amine component that is at least one of diethyltoluenediamine, polyoxypropylene diamine, 2,4,6-tris(dimethylaminomethyl)phenol, or any combination thereof. 7. The method of claim 1 , further comprising curing the curable composition, to provide a cured product of the curable composition, wherein the curing occurs at least partially above-surface. 8. The method of claim 1 , further comprising curing the curable composition, to provide a cured product of the curable composition, wherein the curing occurs at least partially in the subterranean formation. 9. The method of claim 1 , wherein the curable organic resin comprises a diepoxide-substituted phenyl(C 1 -C 10 ) hydrocarbylphenyl, wherein the phenyl and (C 1 -C 10 ) hydrocarbyl are each independently substituted or unsubstituted. 10. The method of claim 1 , wherein the curable organic resin comprises diglycidyl ether of bisphenol A, cyclohexanedimethanol diglycidyl ether, or a combination thereof. 11. The method of claim 1 , wherein the organophilically-modified clay has a density of about 200 kg/m 3 to about 500 kg/m 3 . 12. The method of claim 1 , wherein the organophilically-modified clay has a particle size of about 1 micron to about 500 microns. 13. The method of claim 1 , wherein at least one organophilic-modification compound or an ion thereof is about 10 wt % to about 50 wt % of the at least one organophilically-modified clay. 14. The method of claim 1 , wherein the curable composition has a density of about 200 kg/m 3 to about 3,000 kg/m 3 . 15. The method of claim 1 , wherein the organophilically-modified clay is about 1 wt % to about 20 wt % of the curable composition. 16. The method of claim 1 , wherein the organophilically-modified clay comprises at least one of kaolinite, montmorillonite, illite, and chlorite. 17. The method of claim 1 , further comprising fracturing at least part of the subterranean formation with the curable composition to form at least one subterranean fracture. 18. The method of claim 1 , further comprising cementing or repairing a wellbore in the subterranean formation. 19. A system for performing the method of claim 1 , the system comprising: a tubular disposed in the subterranean formation; and a pump configured to pump the curable composition in the subterranean formation through the tubular. 20. A curable composition for treatment of a subterranean formation, composition comprising: at least one of a curable organic resin and a thermosetting polymer; and an organophilically-modified clay comprising an organophilic-modification compound or an ion thereof, wherein the organophilic-modification compound is at least one of a substituted or unsubstituted (C 10 -C 50 ) fatty acid or a salt thereof, a tri- or tetra-(C 1 -C 50 ) hydrocarbylammonium salt, a tri- or tetra-(C 1 -C 50 ) hydrocarbylphosphonium salt, or combinations thereof, and wherein each tri- or tetra-(C 1 -C 50 ) hydrocarbylammonium salt, and tri- or tetra-(C 1 -C 50 ) hydrocarbylphosphonium salt is independently selected, is substituted or unsubstituted, and is interrupted by 0, 1, 2, or 3 atoms chosen from at least one of —O—, —S—, substituted or unsubstituted —NH—, or combinations thereof.
Polyepoxides · CPC title
containing organic binders only · CPC title
containing additives for specific purposes · CPC title
Gel breakers other than bacteria or enzymes · CPC title
Organo-modified inorganic compounds, e.g. organo-clays · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.